149 related articles for article (PubMed ID: 3000026)
1. Clinical significance of respiratory infection caused by Branhamella catarrhalis with special reference to beta-lactamase producing strains.
Nagatake T
Tohoku J Exp Med; 1985 Sep; 147(1):1-13. PubMed ID: 3000026
[TBL] [Abstract][Full Text] [Related]
2. In-vitro activity of ampicillin/sulbactam and other antibiotics against clinical isolates of Haemophilus sp. and Branhamella catarrhalis.
Stefani S; Russo G; Pellegrino MB; Mezzatesta ML; Cocuzza C; Nicoletti G
J Chemother; 1990 Feb; 2(1):26-30. PubMed ID: 2110245
[TBL] [Abstract][Full Text] [Related]
3. Clinical and bacteriological evaluation of Branhamella catarrhalis in respiratory infections.
Saito A; Yamaguchi K; Shigeno Y; Kohno S; Shigeno H; Kusano N; Dotsu Y; Hara K
Drugs; 1986; 31 Suppl 3():87-92. PubMed ID: 3488201
[TBL] [Abstract][Full Text] [Related]
4. Moraxella (Branhamella) catarrhalis--clinical and molecular aspects of a rediscovered pathogen.
Enright MC; McKenzie H
J Med Microbiol; 1997 May; 46(5):360-71. PubMed ID: 9152030
[TBL] [Abstract][Full Text] [Related]
5. Bronchopulmonary infection due to Branhamella catarrhalis.
McLeod DT; Ahmad F; Power JT; Calder MA; Seaton A
Br Med J (Clin Res Ed); 1983 Nov; 287(6403):1446-7. PubMed ID: 6416451
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibilities and beta-lactamase production of 53 clinical isolates of Branhamella catarrhalis.
Alvarez S; Jones M; Holtsclaw-Berk S; Guarderas J; Berk SL
Antimicrob Agents Chemother; 1985 Apr; 27(4):646-7. PubMed ID: 3873905
[TBL] [Abstract][Full Text] [Related]
7. Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study: microbiology from the medical office practice environment.
Pfaller MA; Ehrhardt AF; Jones RN
Am J Med; 2001 Dec; 111 Suppl 9A():4S-12S; discussion 36S-38S. PubMed ID: 11755437
[TBL] [Abstract][Full Text] [Related]
8. [Respiratory infections caused by Branhamella catarrhalis in 5 different hospitals].
Matsumoto K; Nakayama T; Rikitomi N; Yoshida T; Oishi K; Takahashi A; Tanaka H; Suzuki H; Nagatake T; Ide M
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Mar; 28(3):448-56. PubMed ID: 2120497
[TBL] [Abstract][Full Text] [Related]
9. Upper respiratory tract infections. Ecological and therapeutic aspects of beta-lactamase production with special reference to Branhamella catarrhalis.
Eliasson I; Kamme C
Drugs; 1986; 31 Suppl 3():116-21. PubMed ID: 3488190
[TBL] [Abstract][Full Text] [Related]
10. [Branhamella catarrhalis: incidence in pulmonary infections and determination of sensitivity to 5 antibiotics].
Texier-Maugein J; Escoubas J; Fouche J; Mormede M
Pathol Biol (Paris); 1988 May; 36(5):540-3. PubMed ID: 3136431
[TBL] [Abstract][Full Text] [Related]
11. Detection, distribution and inhibition of Branhamella catarrhalis beta-lactamases.
Philippon A; Riou JY; Guibourdenche M; Sotolongo F
Drugs; 1986; 31 Suppl 3():64-9. PubMed ID: 3015547
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic-sensitivity of Moraxella catarrhalis isolated from clinical materials in 1997-1998.
Mikucka A; Janicka G; Krawiecka D; Kochanowska J
Med Sci Monit; 2000; 6(2):300-4. PubMed ID: 11208326
[TBL] [Abstract][Full Text] [Related]
13. Clinical interpretation of beta-lactamase-producing strains of Branhamella catarrhalis in sputum Gram's stain and culture.
Robinson A; Johnson PC; Griffith SB
Am J Clin Pathol; 1987 Apr; 87(4):498-503. PubMed ID: 3548321
[TBL] [Abstract][Full Text] [Related]
14. The PROTEKT surveillance study: antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections.
Hoban D; Felmingham D
J Antimicrob Chemother; 2002 Sep; 50 Suppl S1():49-59. PubMed ID: 12239228
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China.
Yang Q; Xu Y; Chen M; Wang H; Sun H; Hu Y; Zhang R; Duan Q; Zhuo C; Cao B; Liu Y; Yu Y; Sun Z; Chu Y
Diagn Microbiol Infect Dis; 2012 Jun; 73(2):187-91. PubMed ID: 22521692
[TBL] [Abstract][Full Text] [Related]
16. [Branhamella catarrhalis in respiratory infections].
Marín Casanova P; García-Martos P; Fernández Fatou B; Bernal García F; Agudo Pérez E
Rev Clin Esp; 1989 May; 184(8):399-400. PubMed ID: 2506614
[TBL] [Abstract][Full Text] [Related]
17. [Susceptibility of bacteria isolated from the patients with lower respiratory tract infections to antibiotics (1985)].
Ikemoto H; Watanabe K; Kosakai N; Hayashi Y; Oguri T; Saito A; Shinohara M; Matsumiya H; Ueda K; Terai T
Jpn J Antibiot; 1987 Sep; 40(9):1669-97. PubMed ID: 3121887
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella (Branhamella) catarrhalis isolated in the UK from sputa.
Powell M; McVey D; Kassim MH; Chen HY; Williams JD
J Antimicrob Chemother; 1991 Aug; 28(2):249-59. PubMed ID: 1778856
[TBL] [Abstract][Full Text] [Related]
19. [Serotype distribution and drug resistance of
Tian HL; Shi W; Zhou HF; Yuan L; Yao KH; Rexiati D; Xu AM
Zhonghua Er Ke Za Zhi; 2018 Apr; 56(4):279-283. PubMed ID: 29614568
[No Abstract] [Full Text] [Related]
20. Branhamella catarrhalis: an unappreciated pulmonary pathogen.
Roth RM; Gleckman RA; Hibert DM
Am Fam Physician; 1984 Oct; 30(4):169-73. PubMed ID: 6333806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
